NCT00798304View on ClinicalTrials.gov

Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants

PHASE2TerminatedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions
Meningitis, Meningococcal
Interventions
BIOLOGICAL

meningococcal B rLP2086 vaccine

vaccination

BIOLOGICAL

Routine age appropriate childhood vaccines

vaccination

BIOLOGICAL

meningococcal B rLP2086 vaccine

vaccination

BIOLOGICAL

Routine age appropriate childhood vaccines

vaccination

BIOLOGICAL

Routine age appropriate childhood vaccines

vaccination

Trial Locations (7)

4007

Clínica Mediterráneo, Almería

15706

Hospital Clinico Universitario de Santiago, Santiado de Compostela

28007

Hospital Gral. Gregorio Maranon, Madrid

28041

Hospital 12 de Octubre Materno-Infantil Unidad de Lactantes, Madrid

28935

Hospital Universitario de Mostóles, Mostóles

31008

Hospital Virgen del Camino, Pamplona

36024

Hospital Xeral de Vigo, Vigo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY